- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal COVID-19 vaccines: From bench to bed
Authors
Keywords
COVID-19, SARS-CoV-2, Intranasal vaccine, Mucosal, Adjuvant
Journal
EBioMedicine
Volume 76, Issue -, Pages 103841
Publisher
Elsevier BV
Online
2022-01-25
DOI
10.1016/j.ebiom.2022.103841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS‐CoV‐2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice
- (2021) Jia He et al. JOURNAL OF MEDICAL VIROLOGY
- Looking beyond COVID-19 vaccine phase 3 trials
- (2021) Jerome H. Kim et al. NATURE MEDICINE
- Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses
- (2021) Young Min Son et al. Science Immunology
- T resident helper cells promote humoral responses in the lung
- (2021) Nivedya Swarnalekha et al. Science Immunology
- Intranasal Administration of a Recombinant RBD Vaccine Induced Protective Immunity Against SARS-CoV-2 in Mouse
- (2021) Yingying Du et al. VACCINE
- Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
- (2021) Young-Il Kim et al. mBio
- Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
- (2021) Shaswath S. Chandrasekar et al. Vaccines
- A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice
- (2021) Eun Kim et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Nasal vaccination against SARS-CoV-2: synergistic or alternative to intramuscular vaccines?
- (2021) Mattia Tiboni et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development
- (2021) Shima Moradi-kalbolandi et al. Probiotics and Antimicrobial Proteins
- Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters
- (2021) Qingmei Jia et al. npj Vaccines
- ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
- (2021) Glenn A. Marsh et al. npj Vaccines
- Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells
- (2021) Kavya Rakhra et al. Science Immunology
- Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
- (2021) Yongjun Sui et al. JCI Insight
- Delivery Routes for COVID-19 Vaccines
- (2021) Jang Hyun Park et al. Vaccines
- Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
- (2021) Vivek P. Chavda et al. DRUG DISCOVERY TODAY
- Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
- (2021) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
- (2021) Neeltje van Doremalen et al. Science Translational Medicine
- Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs
- (2021) Jesús Horacio Lara-Puente et al. mBio
- Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice
- (2021) Adrian Rice et al. Scientific Reports
- An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
- (2021) Ahmed O. Hassan et al. Cell Reports
- A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
- (2021) Traci L. Bricker et al. Cell Reports
- A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
- (2021) Sonia Jangra et al. Frontiers in Immunology
- Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5–based COVID-19 vaccine
- (2021) Dong An et al. Science Advances
- A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model
- (2021) Surapong Koonpaew et al. Vaccines
- Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge
- (2021) R. Glenn King et al. Vaccines
- Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
- (2021) Xingyue An et al. iScience
- Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
- (2021) Jun-Gyu Park et al. iScience
- Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle
- (2021) Uday S. Kumar et al. ACS Nano
- Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2
- (2021) Letian Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Intranasal vaccine: Factors to consider in research and development
- (2021) Haiyue Xu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
- (2021) Weina Sun et al. Nature Communications
- Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease
- (2021) Bryce M. Warner et al. iScience
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
- (2020) Young-Il Kim et al. Cell Host & Microbe
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Potential influence of COVID-19/ACE2 on the female reproductive system
- (2020) Yan Jing et al. MOLECULAR HUMAN REPRODUCTION
- Resistance of children to Covid-19. How?
- (2020) Alain Fischer Mucosal Immunology
- Molecular mechanisms and cellular functions of cGAS–STING signalling
- (2020) Karl-Peter Hopfner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Retrograde migration supplies resident memory T cells to lung-draining LN after influenza infection
- (2020) J. Michael Stolley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Long-term maintenance of lung resident memory T cells is mediated by persistent antigen
- (2020) Ida Uddbäck et al. Mucosal Immunology
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
- (2020) Julio Villena et al. Frontiers in Physiology
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection
- (2020) Valentina Bernasconi et al. Mucosal Immunology
- Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice
- (2020) Andrea N. Loes et al. Viruses-Basel
- An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
- (2020) Liqiang Feng et al. Nature Communications
- A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
- (2020) Shipo Wu et al. Nature Communications
- Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
- (2020) Rajat Mudgal et al. Human Vaccines & Immunotherapeutics
- Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection
- (2020) Sang Heui Seo et al. Vaccines
- Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
- (2020) Min-Wen Ku et al. Cell Host & Microbe
- The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery
- (2020) Soojin Shim et al. Marine Drugs
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Complement Factors in COVID-19 Therapeutics and Vaccines
- (2020) Liriye Kurtovic et al. TRENDS IN IMMUNOLOGY
- A randomized, double-blind, controlled clinical trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with adjuvant LTh(αK): A phase I study
- (2019) Sung-Ching Pan et al. VACCINE
- Poly(I:C) alters placental and fetal brain amino acid transport in a rat model of maternal immune activation
- (2019) Eliza R. McColl et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Recent advances in aerosolised drug delivery
- (2019) Akshay Chandel et al. BIOMEDICINE & PHARMACOTHERAPY
- Immunomodulatory properties of chitosan polymers
- (2018) Hannah B.T. Moran et al. BIOMATERIALS
- Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells
- (2018) Aideen C. Allen et al. Mucosal Immunology
- Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine
- (2018) Sachin G. Thakkar et al. JOURNAL OF CONTROLLED RELEASE
- Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi
- (2017) Marina N. Matos et al. PLoS Neglected Tropical Diseases
- RIG-I: a multifunctional protein beyond a pattern recognition receptor
- (2017) Xiao-xiao Xu et al. Protein & Cell
- Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge
- (2017) Manli Wu et al. Frontiers in Cellular and Infection Microbiology
- Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1–2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens
- (2017) Li Song et al. Frontiers in Immunology
- Vaccine technologies: From whole organisms to rationally designed protein assemblies
- (2016) Christopher P. Karch et al. BIOCHEMICAL PHARMACOLOGY
- The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
- (2016) Elizabeth. C. Carroll et al. IMMUNITY
- Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
- (2015) Shujing Wang et al. Protein & Cell
- Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans
- (2014) Edgar Turner Overton et al. VACCINE
- Nasal immunity is an ancient arm of the mucosal immune system of vertebrates
- (2014) Luca Tacchi et al. Nature Communications
- Innate endogenous adjuvants prime to desirable immune responses via mucosal routes
- (2014) Xiaoguang Wang et al. Protein & Cell
- Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
- (2013) Chompoonuch Sawaengsak et al. AAPS PHARMSCITECH
- Lung Airway-Surveilling CXCR3hi Memory CD8+ T Cells Are Critical for Protection against Influenza A Virus
- (2013) Bram Slütter et al. IMMUNITY
- Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
- (2013) J. S. Richardson et al. JOURNAL OF VIROLOGY
- Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces
- (2013) Blaise Corthésy Frontiers in Immunology
- Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
- (2012) Frank Wegmann et al. NATURE BIOTECHNOLOGY
- Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase
- (2012) R. S. Lijek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nasal and skin delivery of IC31®-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes
- (2012) Benjamin Wizel et al. VACCINE
- Strategies for intranasal delivery of vaccines
- (2012) Mehfuz Zaman et al. Drug Delivery and Translational Research
- Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice
- (2011) Suzanne M. Bal et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Chitosan Nanoparticles Act as an Adjuvant to Promote both Th1 and Th2 Immune Responses Induced by Ovalbumin in Mice
- (2011) Zheng-Shun Wen et al. Marine Drugs
- Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine
- (2011) Mark S. Riddle et al. VACCINE
- Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant
- (2010) Zhiwei Sui et al. ARCHIVES OF VIROLOGY
- An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like Particles
- (2010) L. S. Velasquez et al. Clinical and Vaccine Immunology
- Immunity against mucosal pathogens
- (2010) Jennelle Kyd Human vaccines & immunotherapeutics
- Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins
- (2010) N Lycke et al. Mucosal Immunology
- The role of secretory antibodies in infection immunity
- (2010) Richard A. Strugnell et al. NATURE REVIEWS MICROBIOLOGY
- An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine
- (2010) Yoon-Sook Lee et al. VACCINE
- The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
- (2008) C. Trumpfheller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now